Admelog, Humalog, Liprolog, Liumjev, Lyumjev (insulin lispro) is a protein pharmaceutical. Insulin lispro was first approved as Admelog on 1996-04-30. It is used to treat hyperglycemia, type 1 diabetes mellitus, and type 2 diabetes mellitus in the USA. It has been approved in Europe to treat diabetes mellitus.
|Trade Name||Humalog, Liprolog, Liumjev, Lyumjev|
|Common Name||Insulin lispro|
|Indication||diabetes mellitus, hyperglycemia, type 1 diabetes mellitus, type 2 diabetes mellitus|